Back
NeoGenomics Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
70
NEO
NeoGenomics
Last Price:
17.89
Seasonality Move:
59.24%
Sell
45
APLS
Apellis Pharmaceuticals
Last Price:
32.74
Seasonality Move:
13.06%
Buy
70
NeoGenomics (NEO)
is a Buy
Is NeoGenomics a Buy, Sell or Hold?
- The current NeoGenomics [NEO] share price is $17.90. The Score for NEO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- NEO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.74. The Score for APLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $17.90
The current trend is moderately bullish and NEO is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.74
The current trend is moderately bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
NEO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 62.9 | Buy |
Chaikin Money Flow: | -518521 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.69 - 17.89) | Buy |
Bollinger Bands (100): | (14.21 - 17.05) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.35 | Buy |
Relative Strength Index (14 RSI): | 53.96 | Buy |
Chaikin Money Flow: | -1189342 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.32 - 34.2) | Buy |
Bollinger Bands (100): | (28.31 - 37.73) | Sell |
NEO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.9 | Buy |
20-day SMA: | 16.96 | Buy |
50-day SMA: | 15.26 | Buy |
200-day SMA: | 15.05 | Buy |
8-day EMA: | 17.85 | Buy |
20-day EMA: | 17.12 | Buy |
50-day EMA: | 16.09 | Buy |
200-day EMA: | 15.36 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.01 | Sell |
20-day SMA: | 31.78 | Buy |
50-day SMA: | 29.42 | Buy |
200-day SMA: | 40.13 | Sell |
8-day EMA: | 33.66 | Sell |
20-day EMA: | 32.39 | Buy |
50-day EMA: | 31.51 | Buy |
200-day EMA: | 38.78 | Sell |
NeoGenomics Earnings Growth & NEO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.10 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
NeoGenomics Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |